GlassScriptPhysician profile
David C Holmes
NPI 1760443667
$1,285.36
in general payments reported to CMS, 2019-2025
8 companies · $704 in 2025
The $704 reported for 2025 was more than what 85% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.52 · 2024: $551 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $402.98 | 2024 | Vistaseal, Evarrest, Stratafix |
| Atricure, INC. | $374.13 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryoablation System (Cryo2) |
| Abiomed | $194.56 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $119.89 | 2025 | Cobenfy |
| Edwards Lifesciences Corporation | $90.03 | 2022-2024 | Mitris Resilia Mitral Valve |
| Neurocrine Biosciences, INC. | $50.69 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $29.30 | 2024 | Abilify Maintena, Abilify Asimtufii |
| Grifols USA, LLC | $23.78 | 2025 | Thrombate III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.